From October 1, 2022 to November 21, 2022, the company has repurchased 1,211,505 shares, representing 0.22% for CNY 55.98 million. With this, the company has completed the repurchase of 2,022,344 shares, representing 0.37% for CNY 100 million under the buyback announced on August 4, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.98 CNY | +2.10% | +5.14% | -32.49% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.49% | 1.28B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 300363 Stock
- News Porton Pharma Solutions Ltd.
- Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on August 4, 2022.